Cancer Chemother Rep. 1972 Feb; 56(1): 71-82.

Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.

Dombernowsky P, Nissen NI, Larsen V.